UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

  

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period endedJune 30, 2015

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from   to   

 

Commission file number 0-16079

 

  AIR METHODS CORPORATION  
(Exact name of Registrant as Specified in Its Charter)

 

  Delaware       84-0915893  
(State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification Number)

 

7301 South Peoria, Englewood, Colorado     80112  
 (Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code (303) 792-7400

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒  No  ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒  No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated Filer ☒ Accelerated Filer ☐
Non-accelerated Filer ☐  (Do not check if a smaller reporting company) Smaller reporting company ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes ☐  No  ☒

 

The number of shares of Common Stock outstanding as of July 31, 2015, was 39,293,457.

 

 

 
 

 

TABLE OF CONTENTS

         
PART I. FINANCIAL INFORMATION    
         
  Item 1. Condensed Consolidated Financial Statements (unaudited)    
         
    Condensed Consolidated Balance Sheets – June 30, 2015 and December 31, 2014   1
         
    Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2015 and 2014   3
         
    Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2015 and 2014   5
         
    Notes to Condensed Consolidated Financial Statements   7
         
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   13
         
  Item 3. Quantitative and Qualitative Disclosures about Market Risk   20
         
  Item 4. Controls and Procedures   20
       
PART II. OTHER INFORMATION    
       
  Item 1. Legal Proceedings   21
         
  Item 1A. Risk Factors   21
         
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   21
         
  Item 3. Defaults upon Senior Securities   21
         
  Item 4. Mine Safety Disclosures   21
         
  Item 5. Other Information   21
         
  Item 6. Exhibits   21
       
  SIGNATURES   22

 

 
 

 

PART I: FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements

 

Air Methods Corporation and Subsidiaries 

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands, except share and per share amounts)

(unaudited)

 

    June 30,     December 31,  
    2015     2014  
Assets            
             
Current assets:            
Cash and cash equivalents   $ 28,861       13,165  
Receivables:                
Trade, net (note 4)     306,114       293,985  
Refundable income taxes     --       8,865  
Other     2,976       4,802  
Total receivables     309,090       307,652  
                 
Inventories     46,186       46,095  
Work-in-process on medical interiors and products contracts     3,327       4,610  
Assets held for sale     11,265       8,608  
Costs and estimated earnings in excess of billings on uncompleted contracts     1,510       564  
Refundable deposits     10,016       8,381  
Prepaid expenses and other (note 6)     8,373       10,766  
                 
Total current assets     418,628       399,841  
                 
Property and equipment:                
Land     251       251  
Flight and ground support equipment     757,270       697,444  
Aircraft under capital leases     182,188       196,302  
Aircraft rotable spare parts     36,796       38,050  
Buildings and office equipment     61,565       57,983  
      1,038,070       990,030  
Less accumulated depreciation and amortization     (286,536 )     (268,049 )
                 
Net property and equipment     751,534       721,981  
                 
Goodwill (note 2)     127,269       127,269  
Intangible assets, net of accumulated amortization of $21,811 and $19,282 at June 30, 2015 and December 31, 2014, respectively     114,639       83,654  
Other assets     31,640       28,560  
                 
Total assets   $ 1,443,710       1,361,305  

 

 (Continued)

 

1
 

 

Air Methods Corporation and Subsidiaries  

CONDENSED CONSOLIDATED BALANCE SHEETS, Continued

(Amounts in thousands, except share and per share amounts)

(unaudited)

 

    June 30,     December 31,  
    2015     2014  
Liabilities and Stockholders’ Equity            
             
Current liabilities:            
Notes payable   $ 16,314       11,442  
Current installments of long-term debt     47,526       45,827  
Current installments of obligations under capital leases     22,365       23,954  
Accounts payable     21,985       17,393  
Deferred revenue     4,710       4,409  
Billings in excess of costs and estimated earnings on uncompleted contracts     2,310       1,313  
Accrued wages and compensated absences     27,270       31,539  
Due to third party payers     9,699       7,426  
Deferred income taxes     16,536       21,427  
Other accrued liabilities     33,041       15,537  
                 
Total current liabilities     201,756       180,267  
                 
Long-term debt, less current installments     496,440       466,839  
Obligations under capital leases, less current installments     81,561       96,534  
Deferred income taxes     129,889       122,715  
Other liabilities     11,521       16,060  
                 
Total liabilities     921,167       882,415  
                 
Redeemable non-controlling interests     7,582       6,981  
                 
Stockholders’ equity (note 3):                
Preferred stock, $1 par value.  Authorized 15,000,000 shares, none issued     --       --  
Common stock, $.06 par value. Authorized 70,500,000 shares; issued 39,500,652 and 39,452,753 shares at June 30, 2015 and December 31, 2014, respectively; outstanding 39,278,291 and 39,228,948 shares at June 30, 2015 and December 31, 2014, respectively           2,352             2,349  
Additional paid-in capital     124,560       120,391  
Retained earnings     389,145       349,805  
Accumulated other comprehensive loss     (1,096 )     (636 )
                 
Total stockholders’ equity     514,961       471,909  
                 
Total liabilities and stockholders’ equity   $ 1,443,710       1,361,305  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

2
 

 

 

Air Methods Corporation and Subsidiaries 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 

(Amounts in thousands, except share and per share amounts) 

(unaudited)

 

   

Three Months Ended 

June 30, 

   

Six Months Ended 

 June 30, 

 
    2015     2014     2015     2014  
Revenue:                        
Patient transport revenue, net of provision for contractual discounts (note 4)   $ 355,607     $ 297,212       646,643       545,741  
Provision for uncompensated care (note 4)     (173,347 )     (126,673 )     (302,567 )     (233,340 )
Patient transport revenue, net     182,260       170,539       344,076       312,401  
Air medical services contract revenue     38,775       45,790       79,414       90,551  
Tourism and charter revenue     34,444       31,430       62,665       55,768  
Medical interiors and products revenue     4,450       7,404       8,587       15,224  
Dispatch and billing service revenue     3,673       2,474       7,159       4,762  
      263,602       257,637       501,901       478,706  
Operating expenses:                                
Flight centers     98,619       86,561       192,411       174,016  
Aircraft operations (note 6)     31,229       31,720       68,569       63,246  
Tourism operating expenses     23,092       19,476       42,943       35,476  
Cost of medical interiors and products sold     3,529       6,538       6,730       13,217  
Cost of dispatch and billing services     3,090       2,395       5,911       4,924  
Depreciation and amortization     21,154       20,123       41,198       40,495  
Loss on disposition of assets, net     531       806       269       1,213  
General and administrative     33,622        35,807       69,347       67,132  
      214,866       203,426       427,378       399,719  
                                 
Operating income     48,736       54,211       74,523       78,987  
                                 
Other income (expense):                                
Interest expense     (5,163 )     (5,569 )     (10,148 )     (11,097 )
Other, net     1,172       292       1,536       266  
                                 
Income from continuing operations before income taxes     44,745       48,934       65,911       68,156  
Income tax expense     (17,339 )     (19,132 )     (25,629 )     (26,777 )
                                 
Income from continuing operations     27,406       29,802       40,282       41,379  
Loss on discontinued operations, net of income taxes (note 2)     (340 )     (878 )     (349 )     (1,403 )
                                 
Net income     27,066       28,924       39,933       39,976  
Less net income attributable to redeemable non-controlling interests     243       134       482       297  
                                 
Net income attributable to Air Methods Corporation and subsidiaries   $ 26,823     $ 28,790       39,451       39,679  
                                 
Other comprehensive income (loss), net of income taxes:                                
Foreign currency translation adjustments     (85 )     111       (460 )     46  
                                 

Comprehensive income

  $ 26,738     $ 28,901       38,991       39,725  

 

(Continued)

 

3
 

 

Air Methods Corporation and Subsidiaries 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME, continued 

(Amounts in thousands, except share and per share amounts) 

(unaudited)

 

   

Three Months Ended 

June 30,

   

Six Months Ended 

June 30, 

 
    2015     2014     2015     2014  
                         
Income per common share (note 5):                        
Basic:                        
Continuing operations   $ .69       .75       1.01       1.05  
Discontinued operations     (.01 )     (.02 )     (.01 )     (.04 )
Net income   $ .68       .73       1.00       1.01  
                                 
Diluted:                                
Continuing operations   $ .69       .75       1.01       1.05  
Discontinued operations     (.01 )     (.02 )     (.01 )     (.04 )
Net income   $ .68       .73       1.00       1.01  
                                 
Weighted average number of common shares outstanding – basic     39,272,325       39,151,012       39,267,222       39,135,292  
Weighted average number of common shares outstanding – diluted     39,405,889       39,318,480       39,400,193       39,314,872  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

4
 

 

Air Methods Corporation and Subsidiaries 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(unaudited)

 

    Six Months Ended June 30,  
    2015     2014  
             
Cash flows from operating activities:            
Net income   $ 39,933     $ 39,976  
Loss from discontinued operations, net of income taxes     349       1,403  
Adjustments to reconcile net income to net cash provided by operating activities:                
Depreciation and amortization expense     41,198       40,495  
Deferred income tax expense     2,491       9,207  
Stock-based compensation     3,604       1,513  
Tax benefit from exercise of stock options     (160 )     (1,010 )
Loss on disposition of assets, net     269       1,213  
Unrealized loss on derivative instrument     256       64  
Loss from equity method investee     353       603  
Changes in assets and liabilities, net of effects of acquisitions:                
Decrease (increase) in prepaid expenses and other current assets     502       (399 )
Increase in receivables     (1,605 )     (32,492 )
Decrease in inventories     1,192       2,162  
Decrease (increase) in costs in excess of billings     (946 )     1,375  
Increase in accounts payable, other accrued liabilities, and other liabilities     19,492       11,881  
Increase (decrease) in deferred revenue and billings in excess of costs     1,298       (1,398 )
                 
Net cash provided by continuing operating activities     108,226       74,593  
Net cash used by discontinued operating activities     (47 )     (1,198 )
Net cash provided by operating activities     108,179       73,395  
                 
Cash flows from investing activities:                
Acquisition of subsidiaries     --       (3,182 )
Acquisition of property and equipment     (48,355 )     (65,752 )
Acquisition of hospital program     (43,481 )     --  
Buy-out of previously leased aircraft     (7,569 )     (17,296 )
Proceeds from disposition and sale of equipment and assets held for sale     2,664       9,156  
Decrease (increase) in other assets     (10,741 )     447  
Net cash used by continuing investing activities     (107,482 )     (76,627 )
Net cash provided (used) by discontinued investing activities     25       (157 )
Net cash used in investing activities     (107,457 )     (76,784 )

  

 (Continued)


 

5
 

 

Air Methods Corporation and Subsidiaries 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS, Continued

(Amounts in thousands)

(unaudited)

 

    Six Months Ended June 30,  
    2015     2014  
             
Cash flows from financing activities:            
Proceeds from issuance of common stock, net   $ 408       479  
Tax benefit from exercise of stock options     160       1,010  
Borrowings under line of credit     35,000       23,000  
Payments under line of credit     (35,000 )     (22,000 )
Payments for financing costs     (54 )     (75 )
Proceeds from long-term debt     55,321       34,429  
Payments of long-term debt     (24,021 )     (18,803 )
Payments of capital lease obligations     (16,840 )     (21,694 )
Proceeds from non-controlling interests     --       98  
                 
Net cash provided (used) by continuing financing activities     14,974       (3,556 )
Net cash provided (used) by discontinued financing activities     --       --  
Net cash provided (used) by financing activities     14,974       (3,556 )
                 
Increase (decrease) in cash and cash equivalents     15,696       (6,945 )
                 
Cash and cash equivalents at beginning of period     13,165       9,862  
                 
Cash and cash equivalents at end of period   $ 28,861       2,917  
                 
Interest paid in cash during the period   $ 9,799       10,695  
                 
Income taxes paid in cash during the period   $ 3,129       268  

 

Non-cash investing and financing activities:

 

In the six months ended June 30, 2015, the Company entered into non-interest-bearing notes payable of $16,314 to finance the purchase of aircraft which were held in property and equipment pending permanent financing as of June 30, 2015, and into capital leases of $278 to finance the purchase of equipment. The Company also settled non-interest-bearing notes payable of $11,442 in exchange for the aircraft securing the debt.

 

In the six months ended June 30, 2014, the Company entered into non-interest-bearing notes payable of $5,738 to finance the purchase of aircraft which were held in property and equipment pending permanent lease financing as of June 30, 2014, and into capital leases of $548 to finance the purchase of equipment. The Company also settled non-interest-bearing notes payable of $2,616 in exchange for the aircraft securing the debt.

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

6
 

 

Air Methods Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements

(unaudited)

    

(1) Basis of Presentation
   
  The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and instructions to Form 10-Q and Regulation S-X. Accordingly, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the condensed consolidated financial statements for the respective periods. Interim results are not necessarily indicative of results for a full year. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended December 31, 2014.
   
  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company considers its critical accounting policies involving more significant judgments and estimates to be those related to revenue recognition, deferred income taxes, valuation of long-lived assets, and fair values of assets acquired and liabilities assumed in business combinations. Actual results could differ from those estimates.
   
(2) Discontinued Operations
   
  In July 2013, the Company acquired all of the outstanding common stock of American Jets, Inc., and all of the assets of an affiliated entity (collectively, AJI) for a purchase price of approximately $1.7 million. AJI provided long-range fixed wing medical transportation services based out of Florida. Because of operating losses generated in both 2014 and 2013, the Company made the decision during the fourth quarter of 2014 to discontinue all operations conducted by AJI, and all operations ceased in December 2014. Aircraft totaling $1.3 million used in AJI’s operations are included in assets held for sale in the consolidated balance sheet as of June 30, 2015. Goodwill of $1.5 million associated with AJI was written off during the fourth quarter of 2014. All other assets and liabilities associated with AJI are immaterial and will be retained by the Company.
   
  Results of operations for all periods have been reclassified to reflect discontinued operations presentation. Except where otherwise noted, all disclosures in footnotes to the consolidated financial statements represent the results of continuing operations. The results of discontinued operations included in the consolidated statements of comprehensive income were as follows (amounts in thousands):

   

     For quarters ended June 30,  For six months ended June 30,  
     2015    2014    2015      2014  
  Patient transport revenue, net  $--    834    --    2,901 
  Operating expenses:                    
  Depreciation and amortization   --    150    --    294 
  Loss on disposition of assets   561    --    546    -- 
  Other operating expenses   6    2,123    35    4,906 
  Loss from discontinued operations before income taxes   (567)   (1,439)   (581)   (2,299)
  Income tax benefit   227    561    232    896 
  Loss from discontinued operations  $(340)  $(878)  $(349)   (1,403)

 

7
 

 

Air Methods Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements, continued

(unaudited)

  

(3) Stockholders’ Equity
   
  Changes in stockholders’ equity for the six months ended June 30, 2015, consisted of the following (amounts in thousands except share amounts):

 

   Shares   
   Outstanding    Amount  
           
Balances at January 1, 2015   39,228,948   $471,909 
           
Issuance of common shares for options exercised   33,840    408 
Stock-based compensation   15,503    3,604 
Tax benefit from exercise of stock options   --    160 
Forfeiture of unvested restricted shares and related dividends   --    7 
Adjustments to redeemable non-controlling interests   --    (118)
Other comprehensive loss   --    (460)
Net income   --    39,451 
           
Balances at June 30, 2015   39,278,291   $514,961 

   

(4) Patient Transport Revenue Recognition
   
  Trade receivables are presented net of allowances for contractual discounts and uncompensated care. The Company determines its allowances for contractual discounts and uncompensated care based on estimated payer mix, payer reimbursement schedules, and historical collection experience. The allowances are reviewed monthly and adjusted periodically based on actual collections. Billings are charged off against the uncompensated care allowance when it is probable that the receivable will not be recovered. The allowance for contractual discounts is related primarily to Medicare and Medicaid patients. The allowance for uncompensated care is related primarily to receivables recorded for self-pay patients.
   
  The Company has not changed its charitable care policies related to self-pay patients or deductible and copayment balances for insured patients during either 2015 or 2014. The allowance for uncompensated care was 45.4% of receivables from all payers, excluding Medicare and Medicaid, as of June 30, 2015, compared to 38.8% at December 31, 2014, and 39.5% at June 30, 2014. The increase in the allowance reflects a decrease in collections as a percentage of gross charges from third-party payers in 2015 compared to 2014.
   
  The Company recognizes patient transport revenue at its standard rates for services provided, regardless of expected payer. In the period that services are provided and based upon historical experience, the Company records a significant provision for uncompensated care related to uninsured patients who will be unable or unwilling to pay for the services provided and a provision for contractual discounts related to Medicare and Medicaid transports. Patient transport revenue, net of provision for contractual discounts but before provision for uncompensated care, by major payer class, was as follows (amounts in thousands):

  

      For quarter ended June 30,   For six months ended June 30,  
      2015     2014     2015     2014  
                           
Third-party payers   $ 287,343     232,953     510,889     409,819  
Self-pay     68,264     64,259     135,754     135,922  
Total   $ 355,607     297,212     646,643     545,741

  

8
 

 

Air Methods Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements, continued

(unaudited)

 

(5) Income per Share
   
  Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by all common shares outstanding during the period and dilutive potential common shares.
   
   In accordance with FASB ASC 480-10-S99, Distinguishing Liabilities from Equity, and solely for the purpose of calculating earnings per share, net income was decreased by $51,000 and $118,000 for the quarter and six months ended June 30, 2015, respectively, for an adjustment to the value of redeemable non-controlling interests. In the quarter and six months ended June 30, 2014, net income was decreased by $38,000 and increased by $12,000, respectively, for an adjustment to the value of redeemable non-controlling interests.
   
  The reconciliation of basic to diluted weighted average common shares outstanding is as follows:

  

   2015    2014  
For quarter ended June 30:          
Weighted average number of common shares outstanding – basic   39,272,325    39,151,012 
Dilutive effect of:          
Common stock options   35,491    100,970 
Unvested restricted stock   98,073    66,498 
Weighted average number of common shares outstanding – diluted   39,405,889    39,318,480 
           
For six months ended June 30:          
Weighted average number of common shares outstanding – basic   39,267,222    39,135,292 
Dilutive effect of:          
Common stock options   39,226    113,711 
Unvested restricted stock   93,745    65,869 
Weighted average number of common shares outstanding – diluted   39,400,193    39,314,872 

  

  Common stock options totaling 584,832 and 574,832 were not included in the diluted shares outstanding for the quarter and six months ended June 30, 2015, respectively, because their effect would have been anti-dilutive. Common stock options totaling 47,500 were not included in the diluted shares outstanding for the quarter and six months ended June 30, 2014, because their effect would have been anti-dilutive.

  

9
 

  

Air Methods Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements, continued

(unaudited)  

     
(6) Fair Value of Financial Instruments
   
 

ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosures about how fair value is determined for assets and liabilities and establishes a hierarchy by which these assets and liabilities must be grouped based on the type of inputs used in measuring fair value as follows:

   
  Level 1: quoted prices in active markets for identical assets or liabilities;
  Level 2: quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability; or
  Level 3: unobservable inputs, such as discounted cash flow models or valuations.
   
  The following methods and assumptions were used to estimate the fair value of each class of financial instruments:
   
  Cash and cash equivalents, accounts receivable, notes receivable, notes payable, accounts payable, and accrued liabilities:
   
  The carrying amounts approximate fair value because of the short maturity of these instruments.
   
  Derivative instruments:
   
  The Company endeavors to acquire jet fuel at the lowest possible cost and to reduce volatility in operating expenses through the use of short-term purchased call options. Financial derivative instruments covering fuel purchases are included in prepaid expenses and other current assets at fair value. Fair value is determined based on quoted prices in active markets for similar instruments and is classified as Level 2 in the fair value hierarchy. The fair value of all fuel derivative instruments included in prepaid expenses and other current assets was $112,000 at June 30, 2015 and $0 at December 31, 2014. The Company’s financial derivatives do not qualify for hedge accounting, and, therefore, realized and non-cash mark to market adjustments are included in aircraft operations expense in the Company’s statements of comprehensive income. Aircraft operations expense included non-cash mark to market derivative losses of $108,000 and $256,000 for the quarter and six months ended June 30, 2015, respectively, compared to non-cash mark to market losses of $11,000 and $64,000 for the quarter and six months ended June 30, 2014, respectively. There were no cash settlements under the terms of the agreements in 2015 or 2014.
   
  Long-term debt:
   
  The fair value of long-term debt is classified as Level 3 in the fair value hierarchy because it is determined based on the present value of future contractual cash flows discounted at an interest rate that reflects the risks inherent in those cash flows. Based on the borrowing rates currently available to the Company for loans with similar terms and average maturities and on recent transactions, the fair value of long-term debt as of June 30, 2015, is estimated to be $539,539,000, compared to carrying value of $543,966,000. The fair value of long-term debt as of December 31, 2014, was estimated to be $510,353,000, compared to a carrying value of $512,666,000.

 

10
 

 

Air Methods Corporation and Subsidiaries

 Notes to Unaudited Condensed Consolidated Financial Statements, continued

 (unaudited)

       
(7) Business Segment Information  

 

     
  Summarized financial information for the Company’s operating segments is shown in the following table (amounts in thousands). Amounts in the “Corporate Activities” column represent corporate headquarters expenses, corporate income tax expense, and results of insignificant operations. The Company does not allocate assets between all operating segments for internal reporting and performance evaluation purposes. Operating segments and their principal products or services are as follows:
     
  · Air Medical Services (AMS) - provides air medical transportation services to the general population as an independent service and to hospitals or other institutions under exclusive operating agreements. Services include aircraft operation and maintenance, medical care, dispatch and communications, and medical billing and collection.
  · Tourism – provides helicopter tours and charter flights, primarily focusing on Grand Canyon and Hawaiian Island tours.
  · United Rotorcraft (UR) Division - designs, manufactures, and installs aircraft medical interiors and other aerospace and medical transport products for domestic and international customers.
                               
For quarter ended June 30:  AMS   Tourism   UR   Corporate
Activities
   Intersegment
Eliminations
   Consolidated 
2015                              
External revenue  $224,708    34,444    4,449    1    --    263,602 
Intersegment revenue   --    --    4,753    --    (4,753)   -- 
Total revenue   224,708    34,444    9,202    1    (4,753)   263,602 
Operating expenses, excluding depreciation & amortization   (152,269)   (27,421)   (8,418)   (10,177)   4,573    (193,712)
Depreciation & amortization   (17,682)   (1,962)   (907)   (603)   --    (21,154)
Interest expense   (3,750)   (874)   --    (541)   2    (5,163)
Other income, net   1,254    2    --    (82)   (2)   1,172 
Income tax expense   --    --    --    (17,339)   --    (17,339)
Income (loss) from continuing operations   52,261    4,189    (123)   (28,741)   (180)   27,406 
Loss on discontinued operations, net of tax   (340)   --    --    --    --    (340)
Segment net income (loss)   51,921    4,189    (123)   (28,741)   (180)   27,066 
Less net income (loss) attributable to non-controlling interests   (22)   265    --    --    --    243 
Net income (loss) attributable to Air Methods Corporation and subsidiaries  $51,943    3,924    (123)   (28,741)   (180)   26,823 
                               
2014                              
External revenue  $218,777    31,430    7,430    --    --    257,637 
Intersegment revenue   --    --    3,991    --    (3,991)   -- 
Total revenue   218,777    31,430    11,421    --    (3,991)   257,637 
Operating expenses, excluding depreciation & amortization   (142,293)   (24,184)   (10,457)   (9,995)   3,626    (183,303)
Depreciation & amortization   (17,352)   (1,656)   (597)   (518)   --    (20,123)
Interest expense   (4,061)   (731)   --    (777)   --    (5,569)
Other income, net   426    3    --    (137)   --    292 
Income tax expense   --    --    --    (19,132)   --    (19,132)
Income (loss) from continuing operations   55,497    4,862    367    (30,559)   (365)   29,802 
Loss on discontinued operations, net of tax   (878)   --    --    --    --    (878)
Segment net income (loss)   54,619    4,862    367    (30,559)   (365)   28,924 
Less net income (loss) attributable to non-controlling interests   (38)   172    --    --    --    134 
Net income (loss) attributable to Air Methods Corporation and subsidiaries  $54,657    4,690    367    (30,559)   (365)   28,790 

  

11
 

  

Air Methods Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements, continued

(unaudited)

  

(7) Business Segment Information, continued
                               
For six months ended June 30:  AMS    Tourism   UR    Corporate
Activities
 
   Intersegment
Eliminations
   Consolidated 
2015                              
External revenue  $430,649    62,665    8,583    4    --    501,901 
Intersegment revenue   --    --    13,120    --    (13,120)   -- 
Total revenue   430,649    62,665    21,703    4    (13,120)   501,901 
Operating expenses, excluding depreciation & amortization   (306,293)   (51,936)   (19,134)   (20,991)   12,174    (386,180)
Depreciation & amortization   (34,614)   (3,789)   (1,656)   (1,139)   --    (41,198)
Interest expense   (7,422)   (1,656)   --    (1,074)   4    (10,148)
Other income, net   1,815    3    --    (278)   (4)   1,536 
Income tax expense   --    --    --    (25,629)   --    (25,629)
Income (loss) from continuing operations   84,135    5,287    913    (49,107)   (946)   40,282 
Loss on discontinued operations, net of tax   (349)   --    --    --    --    (349)
Segment net income (loss)   83,786    5,287    913    (49,107)   (946)   39,933 
Less net income (loss) attributable to non-controlling interests   (60)   542    --    --    --    482 
Net income (loss) attributable to Air Methods Corporation and subsidiaries  $83,846    4,745    913    (49,107)   (946)   39,451 
                               
2014                              
External revenue  $407,688    55,768    15,250    --    --    478,706 
Intersegment revenue   --    --    7,058    --    (7,058)   -- 
Total revenue   407,688    55,768    22,308    --    (7,058)   478,706 
Operating expenses, excluding depreciation & amortization   (281,758)   (44,195)   (19,967)   (19,506)   6,202    (359,224)
Depreciation & amortization   (35,120)   (3,220)   (1,135)   (1,020)   --    (40,495)
Interest expense   (8,256)   (1,353)   --    (1,488)   --    (11,097)
Other income, net   813    3    --    (550)   --    266 
Income tax expense   --    --    --    (26,777)   --    (26,777)
Income (loss) from continuing operations   83,367    7,003    1,206    (49,341)   (856)   41,379 
Loss on discontinued operations, net of tax   (1,403)   --    --    --    --    (1,403)
Segment net income (loss)   81,964    7,003    1,206    (49,341)   (856)   39,976 
Less net income (loss) attributable to non-controlling interests   (86)   383    --    --    --    297 
Net income (loss) attributable to Air Methods Corporation and subsidiaries  $82,050    6,620    1,206    (49,341)   (856)   39,679 


(8) New Accounting Pronouncements
   
  In April 2015, the FASB issued ASU No. 2015-03, Imputation of Interest: Simplifying the Presentation of Debt Issuance Costs, which requires that debt issuance costs be presented as a deduction from the carrying amount of the debt liability, consistent with debt discounts or premiums. Recognition and measurement guidance for debt issuance costs is not affected by this ASU. The ASU is effective for periods beginning after December 15, 2015, and the Company does not expect the implementation to have a material effect on its financial position or results of operations.
   
  In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. On July 9, 2015, the FASB agreed to defer the effective date for public entities to annual periods beginning after December 15, 2017, although early adoption will be permitted as of the original effective date (i.e., for periods beginning after December 15, 2016). The ASU permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures.

  

12
 

  

ITEM 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

The following discussion of the results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements and notes thereto included in Item 1 of this report. This report, including the information incorporated by reference, contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. The use of any of the words “believe,” “expect,” “anticipate,” “plan,” “estimate,” and similar expressions are intended to identify such statements. Forward-looking statements include statements concerning our possible or assumed future results; flight volume, collection rates and days’ sales outstanding for patient transports; future maintenance costs; size, structure and growth of our air medical services, aerial tourism, and products markets; continuation and/or renewal of hospital contracts; acquisition of new and profitable UR Division contracts; statements concerning our intent to exercise early lease buy-out options on certain aircraft and the means of financing such buy-outs; impact of the Patient Protection and Affordable Care Act (PPACA) and other changes in laws and regulations; and other matters. The actual results that we achieve may differ materially from those discussed in such forward-looking statements due to the risks and uncertainties described in the Risk Factors section of this report, in Management’s Discussion and Analysis of Financial Condition and Results of Operations, and in other sections of this report, as well as in our annual report on Form 10-K. We undertake no obligation to update any forward-looking statements.
     
Overview
     
We provide air medical transportation services throughout the United States and design, manufacture, and install medical aircraft interiors and other aerospace products for domestic and international customers. We also provide tourism operations in and around the Grand Canyon and Hawaiian Islands. Our divisions, or business segments, are organized according to the type of service or product provided and consist of the following:
· Air Medical Services (AMS) - provides air medical transportation services to the general population as an independent service (also called community-based services) and to hospitals or other institutions under exclusive operating agreements (also called hospital-based services). Patient transport revenue consists of flight fees billed directly to patients, their insurers, or governmental agencies, and cash flow is dependent upon collection from these individuals or entities. Air medical services contract revenue consists of fixed monthly fees (approximately 80% of total contract revenue) and hourly flight fees (approximately 20% of total contract revenue) billed to hospitals or other institutions. In the first six months of 2015, the AMS Division generated 86% of our total revenue, compared to 85% in the first six months of 2014.
· Tourism Division – provides helicopter tours and charter flights, primarily focusing on Grand Canyon and Hawaiian Island tours. In the six months ended June 30, 2015 and 2014, the Tourism Division generated 12% of our total revenue.
· United Rotorcraft (UR) Division - designs, manufactures, and installs aircraft medical interiors and other aerospace and medical transport products for domestic and international customers. The UR Division generated 2% of our total revenue in the six months ended June 30, 2015, compared to 3% in 2014.

 

See Note 7 to the condensed consolidated financial statements included in Item 1 of this report for operating results by segment.

 

We believe that the following factors have the greatest impact on our results of operations and financial condition:

 

· Patient transport volume. Almost all patient transport revenue and approximately 20% of AMS contract revenue are derived from flight fees. By contrast, 84% of AMS operating costs incurred during the first six months of 2015 is mainly fixed in nature. While flight volume is affected by many factors, including competition and the effectiveness of marketing and business development initiatives, the greatest single variable in quarterly comparatives has historically been weather conditions. Adverse weather conditions—such as fog, high winds, or heavy precipitation—hamper our ability to operate our aircraft safely and, therefore, result in reduced flight volume. Total patient transports for community-based locations were 16,105 and 29,957 for the quarter and six months ended June 30, 2015, respectively, compared to 14,994 and 27,935 for the quarter and six months ended June 30, 2014, respectively. Patient transports for community-based locations open longer than one year (Same-Base Transports) were 14,380 and 27,023 in the quarter and six months ended June 30, 2015, respectively, compared to 14,698 and 27,404 in the quarter and six months ended June 30, 2014, respectively. Cancellations due to unfavorable weather conditions for community-based locations open longer than one year were 1,250 and 2,255 higher in the quarter and six months ended June 30, 2015, respectively, compared to 2014. Requests for community-based services increased by 4.3% and 5.5% for the quarter and six months ended June 30, 2015, for bases open greater than one year.

 

13
 

  

· Reimbursement per transport. We respond to calls for air medical transports without pre-screening the creditworthiness of the patient and are subject to collection risk for services provided to insured and uninsured patients. Medicare and Medicaid also receive contractual discounts from our standard charges for flight services. Patient transport revenue is recorded net of provisions for contractual discounts and estimated uncompensated care. Both provisions are estimated during the period the related services are performed based on historical collection experience and any known trends or changes in reimbursement rate schedules and payer mix. The provisions are adjusted as required based on actual collections in subsequent periods. Net reimbursement per patient transport is primarily a function of price, payer mix, and timely and effective collection efforts. Both the pace of collections and the ultimate collection rate are affected by the overall health of the U.S. economy, which impacts the number of indigent patients and funding for state-run programs, such as Medicaid. Medicaid reimbursement rates in many jurisdictions have remained well below the cost of providing air medical transportation. The pace of collections is also impacted by additional time taken by private insurers to review claims and related documentation, including proof of medical necessity, prior to processing. One of the primary goals of PPACA is to decrease the number of uninsured Americans. We believe that the movement from self-pay patients to Medicaid in our payer mix shown below is attributable to the expansion of Medicaid eligibility under PPACA. To date, PPACA has not resulted in an increase in the percentage of transports covered by private insurance.
   
  Net reimbursement per transport decreased 0.5% and increased 2.7% in the quarter and six months ended June 30, 2015, compared to 2014, attributed to recent price increases net of deteriorations in payer mix and collection rate. Collections as a percentage of gross charges from private insurers decreased from 81.7% and 81.6% for the quarter and six months ended June 30, 2014, to 77.5% and 77.9% for the quarter and six months ended June 30, 2015, primarily as a result of the cessation of a national contract with one payer. Payer mix, based on number of transports, was as follows:

  

   For quarters ended
June 30,
  For six months ended  
June 30,
   2015  2014  2015    2014  
Private insurance carriers   26.1%   26.9%   26.6%   27.2%
Government-sponsored insurance plans   4.1%   3.6%   3.9%   4.0%
Medicare   35.9%   34.5%   35.4%   34.1%
Medicaid   24.7%   24.1%   24.5%   22.3%
Self-pay patients   9.2%   10.9%   9.6%   12.4%

  

  Provisions for contractual discounts and estimated uncompensated care related to patient transport revenue are as follows:

  

   For quarters ended
June 30,
  For six months ended
June 30,
   2015  2014  2015    2014  
Gross billings   100%   100%   100%   100%
Provision for contractual discounts   52%   51%   53%   51%
Provision for uncompensated care   23%   21%   22%   21%

  

  Although price increases generally increase the net reimbursement per transport from insurance payers, the amount per transport collectible from private patient payers, Medicare, and Medicaid does not increase proportionately with price increases. Therefore, depending upon overall payer mix, price increases will usually result in an increase in the percentage of uncollectible accounts. Certain insurance companies have also not increased their reimbursement rates proportionately with recent price increases to the same extent they did with previous price increases. Continued price increases may cause insurance companies to limit coverage for air medical transport to amounts less than our historical collection rates.
   
· Tourism passenger count. Tourism revenue is entirely derived from passenger fees, but 72% of tourism operating costs incurred during the first six months of 2015 was mainly fixed in nature. Passenger count is impacted by many variables, including weather, competition, and tour prices. Because international travelers account for a significant number of tourism customers, flight volume may also be impacted by worldwide economic conditions and international currency exchange rates. Total tourism passenger count increased to 126,953 and 227,149 in the quarter and six months ended June 30, 2015, respectively, from 113,367 and 200,633 in the quarter and six months ended June 30, 2014, respectively.

 

14
 

 

· Aircraft maintenance. AMS and Tourism operations are directly affected by fluctuations in aircraft maintenance costs. Proper operation of the aircraft by flight crews and standardized maintenance practices can help to contain maintenance costs. Increases in spare parts prices from original equipment manufacturers tend to be higher for aircraft which are no longer in production. One model of aircraft within our fleet, representing 8% of the rotor wing fleet, is no longer in production and is, therefore, susceptible to price increases which outpace general inflationary trends. In addition, on-condition components are more likely to require replacement with age. Since January 1, 2014, we have taken delivery of 28 new aircraft. During the first quarter of 2015, we entered into an agreement to take delivery of 200 Bell 407GXP helicopters beginning in 2016 over a ten-year term, subject to an early termination right exercisable by us. We also have commitments to take delivery of forty other aircraft through the end of 2017. We have replaced discontinued models and other older aircraft with the new aircraft, as well as provided capacity for base expansion. Replacement models of aircraft typically have higher ownership costs than the models targeted for replacement but lower maintenance costs. Total AMS aircraft maintenance expense increased 9.5% and 21.6% for the quarter and six months ended June 30, 2015, respectively, compared to 2014. Total flight hours for AMS operations decreased 1.1% and 0.2% for the quarter and six months ended June 30, 2015, respectively, compared to 2014. Aircraft maintenance expense for the Tourism division increased 49.8% and 36.2% in the quarter and six months ended June 30, 2015, respectively, compared to the first quarter of 2014, corresponding to increases of 5.3% and 7.8% in total flight hours for the quarter and six months ended June 30, 2015, respectively. The changes in maintenance expense reflect normal fluctuations in the timing of overhaul and replacement cycles for aircraft parts. Based on flight hour projections, we expect overhaul and replacement events to decrease in the final two quarters of 2015 compared to the first quarter. During the six months ended June 30, 2015, we also incurred $2.6 million to remediate certification documentation issues related to Night Vision Imaging Systems (NVIS) installations in certain of our aircraft. We do not expect further costs related to this remediation effort.
   
· Competitive pressures from low-cost providers. We are recognized within the industry for our standard of service and our use of cabin-class aircraft. Many of our competitors utilize aircraft with lower ownership and operating costs and do not require a similar level of experience for aviation and medical personnel. Reimbursement rates established by Medicare, Medicaid, and most insurance providers are not contingent upon the type of aircraft used or the experience of personnel. However, we believe that higher quality standards help to differentiate our service from competitors and, therefore, lead to higher utilization.
   
· Employee recruitment and relations. The ability to deliver quality services is partially dependent upon our ability to hire and retain employees who have advanced aviation, nursing, and other technical skills. In addition, hospital contracts typically contain minimum certification requirements for pilots and mechanics. Employees who meet these standards are in great demand and are likely to remain a limited resource in the foreseeable future. Our AMS pilots are represented by a collective bargaining unit and are covered under a collective bargaining agreement which is effective through December 31, 2016. Other employee groups may also elect to be represented by unions in the future.

 

Results of Operations

 

We reported net income of $26,823,000 and $39,451,000 for the quarter and six months ended June 30, 2015, respectively, compared to $28,790,000 and $39,679,000 for the quarter and six months ended June 30, 2014, respectively. Same-Base Transports were 2.2% and 1.4% lower in the quarter and six months ended June 30, 2015, respectively, compared to 2014, while net reimbursement per patient transport decreased 0.5% and increased 2.7% in the quarter and six months ended June 30, 2015, respectively, compared to 2014, primarily as a result of recent price increases net of deteriorations in payer mix and collection rate.

 

15
 

 

Air Medical Services

 

Patient transport revenue is recorded net of provisions for contractual discounts and uncompensated care and increased $11,721,000, or 6.9%, and $31,675,000, or 10.1%, for the quarter and six months ended June 30, 2015, compared to 2014, for the following reasons.

· Decrease of 0.5% and increase of 2.7% in net reimbursement per transport for the quarter and six months ended June 30, 2015, respectively, compared to 2014, due primarily to recent price increases net of deteriorations in payer mix and collection rate. Collections as a percentage of gross charges from private insurers decreased from 81.7% and 81.6% for the quarter and six months ended June 30, 2014, to 77.5% and 77.9% for the quarter and six months ended June 30, 2015, primarily as a result of the cessation of a national contract with one payer.
· Decreases of 318, or 2.2%, and 381, or 1.4%, in Same-Base Transports for the quarter and six months ended June 30, 2015, respectively, compared to 2014. Cancellations due to unfavorable weather conditions for bases open longer than one year were 1,250 and 2,255 higher in the quarter and six months ended June 30, 2015, respectively, compared to 2014. Requests for community-based services increased by 4.3% and 5.5% for the quarter and six months ended June 30, 2015, respectively, for bases open greater than one year.
· Incremental net revenue of $18,859,000 and $35,048,000 for the quarter and six months ended June 30, 2015, respectively, generated from the addition of 28 new bases, including fourteen bases resulting from the conversion of AMS contract customers to community-based operations, during or subsequent to the first six months of 2014.
· Closure of eleven bases during or subsequent to the first six months of 2014, due to insufficient flight volume, resulting in decreases in net revenue of approximately $1,435,000 and $2,654,000 during the quarter and six months ended June 30, 2015, respectively.

 

Air medical services contract revenue decreased $7,015,000, or 15.3%, and $11,137,000, or 12.3%, for the quarter and six months ended June 30, 2015, compared to 2014, for the following reasons:

· Cessation of service under five contracts and the conversion of six contracts to community-based operations during or subsequent to the first six months of 2014, resulting in decreases in net revenue of approximately $7,426,000 and $12,741,000 for the quarter and six months ended June 30, 2015, respectively.
· Incremental net revenue of $526,000 and $1,302,000 for the quarter and six months ended June 30, 2015, generated from the addition of one new air medical services contract in the second quarter of 2014 and the expansion of three contracts to additional bases of operation during or subsequent to the first quarter of 2014.
· Decreases of 1.2% and 1.3% in flight volume for the quarter and six months ended June 30, 2015, respectively, for all contracts excluding new contracts, contract expansions, and closed contracts described above.
· Annual price increases in the majority of contracts based on stipulated contractual increases or changes in the Consumer Price Index or spare parts prices from aircraft manufacturers.

 

Flight center costs (consisting primarily of pilot, mechanic, and medical staff salaries and benefits) increased $12,058,000, or 13.9%, and $18,395,000, or 10.6%, for the quarter and six months ended June 30, 2015, respectively, compared to 2014, for the following reasons:

· Increases of approximately $9,406,000 and $17,008,000 for the quarter and six months ended June 30, 2015, respectively, for the addition of personnel to staff new base locations described above.
· Decreases of approximately $4,062,000 and $8,304,000 for the quarter and six months ended June 30, 2015, respectively, due to the closure of base locations described above.
· Increases in salaries for merit pay raises and in the cost of employee medical benefits.

 

Aircraft operating expenses decreased $491,000, or 1.5%, and increased $5,323,000, or 8.4%, for the quarter and six months ended June 30, 2015, respectively, compared to 2014. Aircraft operating expenses consist of fuel, insurance, and maintenance costs and generally are a function of the size of the fleet, the type of aircraft flown, and the number of hours flown. The change in costs is due to the following:

· Increases in AMS aircraft maintenance expense of $2,126,000, or 9.5%, to $24,568,000 for the second quarter of 2015 and $9,635,000, or 21.6%, to $54,193,000 for the six months ended June 30, 2015, compared to the prior year. Total AMS flight volume decreased 1.1% and 0.2% for the quarter and six months ended June 30, 2015, respectively, compared to prior year. The change in maintenance expense reflects normal fluctuations in the timing of overhaul and replacement cycles for aircraft parts. During the six months ended June 30, 2015, we also incurred $2,635,000 to remediate certification documentation issues related to NVIS installations in certain of our aircraft. We do not expect further costs related to this remediation effort.

  

16
 

 

· Decreases of approximately 32.1% and 29.4% in the cost of aircraft fuel per hour flown for AMS operations for the quarter and six months ended June 30, 2015, respectively. Total AMS fuel costs decreased $1,856,000 to $4,802,000 and $3,045,000 to $9,455,000 for the quarter and six months ended June 30, 2015, respectively, compared to 2014.
· Decrease in hull insurance rates effective July 2014.

 

Tourism

 

Tourism and charter revenue increased $3,014,000, or 9.6%, and $6,897,000, or 12.4%, for the quarter and six months ended June 30, 2015, respectively, compared to 2014. During the quarter and six months ended June 30, 2015, respectively, we transported 126,953 and 227,149 passengers on tourism flights, compared to 113,367 and 200,633 in the quarter and six months ended June 30, 2014, respectively.

 

Tourism operating expenses consist primarily of pilot and mechanic salaries and benefits; aircraft maintenance, fuel, and insurance; landing fees; commissions; and cost of tour amenities and typically vary with passenger count, flight volume, and number and type of aircraft. Expenses increased $3,616,000, or 18.6%, and $7,467,000, or 21.0%, for the quarter and six months ended June 30, 2015, respectively, compared to 2014, in part due to the increase in the number of passengers. Cost of tour amenities for our Grand Canyon operations increased $19,000, or 0.6%, and $1,290,000, or 29.3%, for the quarter and six months ended June 30, 2015, respectively, primarily due to higher access fees charged by the Hualapai Tribe for certain attractions at the Grand Canyon effective May 2014. In addition, tourism aircraft maintenance expense increased $2,254,000, or 49.8%, to $6,776,000 and $3,366,000, or 36.2%, to $12,657,000 for the quarter and six months ended June 30, 2015, respectively, reflecting increases of 5.3% and 7.8% in total flight hours for the quarter and six months ended June 30, 2015, respectively, as well as normal fluctuations in the timing of overhaul and replacement cycles for aircraft parts. In addition, we expanded the tourism fleet from 52 helicopters at June 30, 2014, to 58 helicopters at June 30, 2015. These increases were offset in part by decreases of 21.4% and 22.9% in the cost of aircraft fuel per hour flown for the quarter and six months ended June 30, 2015 and 2014, respectively.

 

Medical Interiors and Products

 

Medical interiors and products revenue decreased $2,954,000, or 39.9%, and $6,637,000, or 43.6%, for the quarter and six months ended June 30, 2015, respectively, compared to 2014. Significant projects during 2015 included the completion of nine multi-mission interiors for the U.S. Army’s HH-60M helicopter and work on three aircraft interiors for commercial customers. Revenue by product line for the quarter and six months ended June 30, 2015, was as follows:

· $2,454,000 and $5,611,000 – governmental entities
· $1,996,000 and $2,976,000 – commercial customers

 

Significant projects in process during 2014 included work on 24 multi-mission interiors for the U.S. Army’s HH-60M helicopter, 35 interiors for an older generation of the U.S. Army’s Black Hawk helicopter, and twelve aircraft interiors for commercial customers. Revenue by product line for the quarter and six months ended June 30, 2014, was as follows:

· $4,674,000 and $9,910,000 – governmental entities
· $2,730,000 and $5,314,000 – commercial customers

 

Cost of medical interiors and products decreased $3,009,000, or 46.0%, and $6,487,000, or 49.1%, for the quarter and six months ended June 30, 2015, respectively, as compared to the prior year, due primarily to the decrease in related revenue. Cost of medical interiors and products also includes certain fixed costs, such as administrative salaries and facilities rent, which do not vary with volume of sales and which are absorbed by both projects for external customers and interdivisional projects.

 

General Expenses

 

General and administrative (G&A) expenses decreased $2,185,000, or 6.1%, and increased $2,215,000, or 3.3%, for the quarter and six months ended June 30, 2015, respectively, compared to 2014. G&A expenses include executive management, legal, accounting and finance, billing and collections, information services, human resources, aviation management, pilot training, dispatch and communications, AMS program administration, and Tourism customer service and reservations. Since March 31, 2014, we have converted six AMS contracts to community-based operations, resulting in fourteen additional bases and contributing to an increase in billing and collections, dispatch, and AMS program administration requirements. Partially offsetting these increases, equity and incentive compensation accruals related to our financial performance decreased $2,658,000 and $427,000 during the quarter and six months ended June 30, 2015, respectively, compared to 2014.

 

17
 

 

Income tax expense was $17,339,000 and $25,629,000 in the quarter and six months ended June 30, 2015, respectively, compared to $19,132,000 and $26,777,000 in the quarter and six months ended June 30, 2014, respectively. The effective tax rate was approximately 38.8% and 38.9% for the quarter and six months ended June 30, 2015, respectively, compared to 39.1% and 39.3% for the quarter and six months ended June 30, 2014. Changes in our effective tax rate are affected by the apportionment of revenue and income before taxes for the various jurisdictions in which we operate and by changing tax laws and regulations in those jurisdictions.

 

Liquidity and Capital Resources

 

Our working capital position as of June 30, 2015, was $216,872,000, compared to $219,574,000 at December 31, 2014. Cash generated by continuing operations was $108,226,000 in 2015, compared to $74,593,000 in 2014, reflecting the results of operations described above. Receivables increased by $1.6 million during 2015, compared to $32.5 million during 2014. Days’ sales outstanding (DSO’s) related to patient transports, measured by comparing net patient transport revenue for the annualized previous six-month period to outstanding open net accounts receivable, were 131 at June 30, 2015, compared to 123 at June 30, 2014. The increase in DSO’s is primarily attributed to additional time taken by private insurers to review claims and related documentation, including proof of medical necessity, prior to processing. We do not expect the claims processing times for private insurers to improve in the near-term. The increase in patient transport receivables caused by increasing DSO’s was offset in part by decreases in other receivables.

 

Cash used by continuing investing activities totaled $107,482,000 in 2015 compared to $76,627,000 in 2014. Equipment acquisitions in the six months ended June 30, 2015, included the purchase of ten aircraft for approximately $34.5 million and the buy-out of seven previously leased aircraft for $7.6 million. During the six months ended June 30, 2015, we also acquired three aircraft, medical equipment, and certain other intangible assets totaling $43.5 million from a hospital customer in connection with converting the program to community-based operations. Equipment acquisitions in the six months ended June 30, 2014, included the buy-out of thirteen previously leased aircraft for approximately $17.3 million and the purchase of fifteen aircraft for approximately $44.6 million. We also sold twelve aircraft for $9.1 million.

 

Continuing financing activities provided $14,974,000 in 2015 compared to using $3,556,000 in 2014. The primary uses of cash in both 2015 and 2014 were regularly scheduled payments of long-term debt and capital lease obligations. During the six months ended June 30, 2015 and 2014, we originated seventeen and eleven notes, respectively, primarily to finance the acquisition of aircraft.

 

We currently intend to exercise early lease buy-out options on up to eight aircraft totaling approximately $14.8 million during the last two quarters of 2015. We expect to finance the buy-outs under long-term notes and with internally generated cash flow or availability under the line of credit.

 

In the first quarter of 2015, we entered into an agreement to purchase 200 Bell 407GXP helicopters totaling $882.6 million over a ten-year term beginning in 2016. In the event we exercise our right to termination for convenience or are prevented from taking or decline to take delivery of the aircraft for any other reason, we may forfeit nonrefundable deposits up to $6.3 million. We intend to use the new aircraft for base expansion opportunities as well as to replace older models of aircraft in the fleet. We plan to either sell the aircraft which are replaced, use them for spare parts, or redeploy them into the backup fleet.

 

Critical Accounting Policies

 

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

18
 

 

On an on-going basis, management evaluates our estimates and judgments, including those related to revenue recognition, deferred income taxes, and valuation of long-lived assets and goodwill. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Management believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Revenue Recognition

 

Revenue relating to tourism and charter flights is recognized upon completion of the services. Fixed contract revenue under our operating agreements with hospitals is recognized monthly over the terms of the agreements. Revenue relating to patient transports is recorded net of provisions for contractual discounts and estimated uncompensated care. Both provisions are estimated during the period related services are performed based on historical collection experience and any known trends or changes in reimbursement rate schedules and payer mix. The provisions are adjusted as required based on actual collections in subsequent periods. We have from time to time experienced delays in reimbursement from third-party payers. In addition, third-party payers may disallow, in whole or in part, claims for reimbursement based on determinations that certain amounts are not reimbursable under plan coverage, determinations of medical necessity, or the need for additional information. Laws and regulations governing Medicare and Medicaid programs are very complex and subject to interpretation. We also provide services to patients who have no insurance or other third-party payer coverage. There can be no guarantee that we will continue to experience the same collection rates that we have in the past. If actual future collections are more or less than those projected by management, adjustments to allowances for contractual discounts and uncompensated care may be required. Based on related patient transport revenue for the six months ended June 30, 2015, a change of 100 basis points in the percentage of estimated contractual discounts and uncompensated care would have resulted in a change of approximately $13,885,000 in patient transport revenue.

 

Revenue related to fixed fee medical interior and products contracts is recorded as costs are incurred using the percentage of completion method of accounting. We estimate the percentage of completion based on costs incurred to date as a percentage of an estimate of the total costs to complete the project. Losses on contracts in process are recognized when determined. If total costs to complete a project are greater or less than estimated, the gross margin on the project may be greater or less than originally recorded under the percentage of completion method.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. On July 9, 2015, the FASB agreed to defer the effective date for public entities to annual periods beginning after December 15, 2017, although early adoption will be permitted as of the original effective date (i.e., for periods beginning after December 15, 2016). The ASU permits the use of either the retrospective or cumulative effect transition method. We have not yet selected a transition method and are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.

 

Deferred Income Taxes

 

In preparation of the consolidated financial statements, we are required to estimate income taxes in each of the jurisdictions in which we operate. This process involves estimating actual current tax exposure together with assessing temporary differences resulting from differing treatment of items, such as depreciable assets, for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included in the consolidated balance sheets. We then assess the likelihood that deferred tax assets will be recoverable from future taxable income in the respective federal or state jurisdiction as appropriate and record a valuation allowance for those amounts we believe are not likely to be realized. We consider estimated future taxable income, tax planning strategies, and the expected timing of reversals of existing temporary differences in assessing the need for a valuation allowance against deferred tax assets. Establishing or increasing a valuation allowance in a period increases income tax expense. In the event we were to determine that we would not be able to realize all or part of our net deferred tax assets in the future, an adjustment to the valuation allowance would be charged to income in the period such determination was made. Likewise, should we determine that we would be able to realize our deferred tax assets in the future in excess of our net recorded amount, an adjustment to the valuation allowance would increase income in the period such determination was made. The effect on deferred income tax assets and liabilities of a change in statutory tax rates applicable to the Company is also recognized in income in the period of the change. We evaluate the recognition and measurement of uncertain tax positions based on the facts and circumstances surrounding the tax position and applicable tax law and other tax pronouncements. Changes in our estimates of uncertain tax positions would be recognized as an adjustment to income tax expense in the period of the change.

 

19
 

 

Long-lived Assets Valuation

 

In accounting for long-lived assets, we make estimates about the expected useful lives, projected residual values and the potential for impairment. Estimates of useful lives and residual values of aircraft are based upon actual industry experience with the same or similar aircraft types and anticipated utilization of the aircraft. Changing market prices of new and used aircraft, government regulations and changes in our maintenance program or operations could result in changes to these estimates. Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. Our cash flow estimates are based on historical results adjusted for estimated current industry trends, the economy, and operating conditions.

 

Goodwill Valuation

 

We evaluate goodwill annually in accordance with ASU No. 2011-08, Testing for Goodwill Impairment, which allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Factors considered include overall economic conditions within our markets, access to capital, changes in the cost of operations, the financial performance of the Company, and change in our stock price during the year. Based upon our qualitative assessment of factors impacting the value of goodwill as of December 31, 2014, we determined that it was not likely that the fair value of any reporting unit was less than its carrying amount and that a quantitative assessment of goodwill was not necessary. Changes in these factors or a sustained decline in general economic conditions could change our conclusion regarding an impairment of goodwill and potentially result in a non-cash impairment loss in a future period. In the fourth quarter of 2014, we wrote off $1.5 million in goodwill related to discontinued operations of American Jets, Inc., as discussed more fully in Note 2 to the consolidated financial statements included in Item 1 of this report.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

There have been no material changes in market risk at June 30, 2015, from that reported in our Annual Report on Form 10-K for the year ended December 31, 2014.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted to the Securities and Exchange Commission (the Commission) under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified by the Commission’s rules and forms, and that information is accumulated and communicated to management, including the principal executive and financial officers (referred to in this report as the Certifying Officers), as appropriate to allow timely decisions regarding required disclosure. Management, under the supervision and with the participation of the Certifying Officers, evaluated the effectiveness of disclosure controls and procedures as of June 30, 2015, pursuant to Rule 13a-15(b) under the Exchange Act. Based on that evaluation, the Certifying Officers have concluded that, as of June 30, 2015, our disclosure controls and procedures were effective.

 

Changes in Internal Control over Financial Reporting

 

There were no significant changes in our internal control over financial reporting that occurred during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

20
 

 

PART II: OTHER INFORMATION

 

Item 1. Legal Proceedings

 

There have been no material changes in legal proceedings from those disclosed in our annual report on Form 10-K for the year ended December 31, 2014.

 

Item 1A. Risk Factors

 

There have been no material changes in our risk factors from those disclosed in our annual report on Form 10-K for the year ended December 31, 2014.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Not Applicable

 

Item 3. Defaults upon Senior Securities

 

Not Applicable

 

Item 4. Mine Safety Disclosures

 

Not Applicable

 

Item 5. Other Information

 

Not Applicable

 

Item 6. Exhibits

 

31.1 Chief Executive Officer Certification adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
31.2 Chief Financial Officer Certification adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32 Certification adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

101.INS XBRL Instance Document
   
101.SCH XBRL Taxonomy Extension Schema Document
   
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
   
101.LAB XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

 

21
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AIR METHODS CORPORATION
       
       
Date: August 7, 2015 By /s/ Aaron D. Todd  
    Aaron D. Todd  
    Chief Executive Officer  
       
Date: August 7, 2015 By /s/ Trent J. Carman  
    Trent J. Carman  
    Chief Financial Officer  
       
Date:  August 7, 2015 By /s/ Sharon J. Keck  
    Sharon J. Keck  
    Chief Accounting Officer  

  

22



 

 

EXHIBIT 31.1

 

CERTIFICATION 

 

I, Aaron D. Todd, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Air Methods Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  

Date: August 7, 2015

 

/s/ Aaron D. Todd  

Aaron D. Todd

Chief Executive Officer

 

 



 

 EXHIBIT 31.2

 

CERTIFICATION

 

 

I, Trent J. Carman, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Air Methods Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 7, 2015

 

/s/ Trent J. Carman  

Trent J. Carman

Chief Financial Officer

 

 



 

 

EXHIBIT 32

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Air Methods Corporation (the “Company”) on Form 10-Q for the period ended June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Aaron D. Todd  
Aaron D. Todd
Chief Executive Officer
August 7, 2015
   
/s/ Trent J. Carman  
Trent J. Carman
Chief Financial Officer
August 7, 2015

 

 

Air Methods Corp. (NASDAQ:AIRM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Air Methods Corp. Charts.
Air Methods Corp. (NASDAQ:AIRM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Air Methods Corp. Charts.